Literature DB >> 3631747

Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia.

K R Stenmark, M Eyzaguirre, J Y Westcott, P M Henson, R C Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3631747     DOI： 10.1164/ajrccm/136.3.770

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  7 in total

1.  Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants.

Authors:  D C Wilson; P Cairns; H L Halliday; M Reid; G McClure; J A Dodge
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

2.  Pulmonary inflammatory cells in ventilated preterm infants: effect of surfactant treatment.

Authors:  S Arnon; J Grigg; M Silverman
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

3.  Effects of indomethacin on prostaglandin E2 and thromboxane B2 contents of tracheal lavage fluids in premature infants.

Authors:  J C Le Guennec; M Lauzière; R Black; P Sirois
Journal:  Inflammation       Date:  1991-02       Impact factor: 4.092

4.  Blood eosinophils, leukotriene C4 generation, and bronchial hyperreactivity in formerly preterm infants.

Authors:  U Schauer; S Alefsen; R Jäger; F Riedel; C H Rieger
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

5.  Respiratory illness in families of preterm infants with chronic lung disease.

Authors:  J P de Winter; L van Sonderen; J N van den Anker; I T Merth; R Brand; F van Bel; H M Zonderland; P H Quanjer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

6.  Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants.

Authors:  S Little; T Dean; S Bevin; M Hall; M Ashton; M Church; J Warner; J Shute
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

7.  Attenuation of amiodarone induced lung fibrosis and phospholipidosis in hamsters, by treatment with the platelet activating factor receptor antagonist, WEB 2086.

Authors:  S N Giri; D M Hyde; D R Haynam; M Casias
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.